Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     ATC
 1  Agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
 
 3  Agents affecting metabolism
 
 4  Agents affecting cellular function
   41  Cellular function activating agents
   42  Antineoplastics
     421  Alkylating agents
     422  Antimetabolites
     423  Antibiotics
     424  Plant extract preparations
       4240  Plant extract preparations
         D01068  Vinblastine sulfate (JP17/USP)
         D02197  Vincristine sulfate (JP17/USP)
         D01769  Vindesine sulfate (JAN/USAN)
         D01935  Vinorelbine tartrate (USP); Vinorelbine ditartrate (JAN)
         D00125  Etoposide (JP17/USP/INN)
         D00491  Paclitaxel (JAN/USP/INN)
         D02165  Docetaxel (USP); Docetaxel hydrate (JP17)
         D07866  Docetaxel (JAN/INN)
         D10452  Cabazitaxel acetonate (JAN)
         D02168  Topotecan hydrochloride (USAN); Nogitecan hydrochloride (JAN)
         D01061  Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP17)
L01CA01
L01CA02
L01CA03
L01CA04
L01CB01
L01CD01
L01CD02
L01CD02
L01CD04
L01XX17
L01XX19
     429  Miscellaneous
   43  Radioactive drugs
   44  Allergic agents
   49  Other agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: February 15, 2020
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version